Secretoneurin as a novel predictor of metabolic syndrome in patients with obstructive sleep apnea syndrome

Objective: This study aimed to evaluate whether Secretoneurin (SN) was elevated in Metabolic Syndrome (MetS) and could serve as a potential predictive biomarker in the development of MetS in patients with Obstructive Sleep Apnea Syndrome (OSAS). Methods: This cross-sectional study included 86 consec...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	İbrahim Arslan, Yasin Aslan, Muzaffer Arı, Hamit Yaşar Ellidağ, Ömer Tarık Selçuk
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-09-01
Цуврал:	Brazilian Journal of Otorhinolaryngology
Нөхцлүүд:	Metabolic syndrome Obstructive sleep apnea Secretoneurin Hypoxia Cardiovascular disease
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S1808869426001059
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!